Skip to main content

Table 5 Univariate and multivariate analysis for overall survival using Cox relative risk

From: MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

Variable Univariate analysis Multivariate analysis
  RR (95% CI) P value1 RR (95% CI) P value1
MPC1 expression in tumor 0.561 0.000 0.654 0.000
  (0.536-0.588)   (0.621-0.690)  
MPC2 expression in tumor 0.558 0.000 0.696 0.000
  (0.533-0.585)   (0.660-0.734)  
Age 0.977 0.000 0.998 0.371
(≤71 year vs >71 year) (0.973-0.981)   (0.994-1.002)  
UICC stage 1.34 0.000 1.198 0.000
(pT2 vs pT3-pT4) (1.259-1.427)   (1.095-1.311)  
Gleason score 1.769 0.000 1.635 0.000
(< 7, 7-10 ) (1.645-1.902)   (1.514-1.765)  
PSA(ng/ml) 1.344 0.000 1.091 0.000
(≤10, > 10 and ≤ 20,> (1.286-1.405)   (1.040-1.143)  
lymph node metastasis 1.361 0.000 0.985 0.742
(positive vs negative) (1.253-1.478)   (0.897-1.080)  
distant metastasis 1.094 0.008 1.049 0.293
(positive vs negative) (1.023-1.170)   (0.960-1.147)  
  1. RR relative risk; 95%CI: 95% confidence interval; 1Cox regression